Quick Answer
LISATA THERAPEUTICS, INC. reported Revenue (ASC 606) of $170.0 thousand for fiscal year 2025.
LISATA THERAPEUTICS, INC. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $170.0K | -83.0% |
| 2024 | $1.00M | — |
| 2023 | $0.00 | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.00 | — | -100.0% |
| June 30, 2025 | $70.0K | — | — |
| September 30, 2024 | $0.00 | — | — |
| June 30, 2024 | $0.00 | — | — |
- LISATA THERAPEUTICS, INC. showed a decrease of -83.0% in Revenue (ASC 606) compared to the prior fiscal year.
- The most recent figure is from LISATA THERAPEUTICS, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: